Chronic Disseminated CandidiasisRetrospective, multicentre case study on patients with chronic disseminated candidiasis / hepatosplenic candidiasis in the age of azole prophylaxis. Cases diagnosed in 2007 and after are being included.

This August issue marks the 25th anniversary of The Lancet Infectious Diseases. The journal was created in 2001 by our late Editor-in-Chief John McConnell whose vision for a journal for specialists in...

Welcome! You are invited to join a meeting: FDAW ISHAM Webinar – Resistance Without Borders: Antifungal Threats Region by Region. After registering, you will receive a confirmation email about joining...

Background Patients with haematological or oncological malignancies are at increased risk of severe infections. Vaccination is a key preventive strategy and is recommended by National Immunization Tec...

Structured digital programs achieve wide global reach and sustained engagement. Strong participation in long-form sessions supports implementing CME accreditation and unrestricted on-demand access to enhance global health equity.

Der Gemeinsame Bundesausschuss stellt der Universität zu Köln und dem Universitätsklinikum Köln Fördermittel in Höhe von einer Million Euro über dreißig Monate zur Verfügung. Besonders profitieren wer...

Purpose Acute respiratory infections (ARI) impose a significant burden on healthcare systems and society. This study aimed to investigate the circulation of respiratory viruses in community-dwelling o...

Here, in a survey of 619 institutions across Latin America and the Caribbean, the authors showcase major gaps in fungal diagnostics and antifungal access, with stark disparities linked to income and i...

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

YouTube video by IDIM IDIM

Workshop Goal To bring together clinicians, researchers, regulators, industry representatives, and public health partners to identify barriers to clinical trial deve

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...